Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Assoc Physicians India ; 71(5): 11-12, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37355828

RESUMO

We describe the case of a patient who came with features suggestive of diabetic ketoacidosis. On further evaluation of DKA, we found that it was caused by acute pancreatitis. This acute pancreatitis was found to be caused by hypercalcemia, which was in turn due to primary hyperparathyroidism. Imaging studies done for hyperparathyroidism revealed a thyroid nodule which later turned out to be malignant. This patient was also incidentally found to have hypertrophic obstructive cardiomyopathy.


Assuntos
Cetoacidose Diabética , Hipercalcemia , Hiperparatireoidismo , Pancreatite , Nódulo da Glândula Tireoide , Humanos , Pancreatite/diagnóstico , Pancreatite/etiologia , Doença Aguda , Hiperparatireoidismo/complicações , Hiperparatireoidismo/diagnóstico , Hiperparatireoidismo/patologia , Nódulo da Glândula Tireoide/complicações , Hipercalcemia/etiologia , Cetoacidose Diabética/diagnóstico
2.
Indian J Crit Care Med ; 27(7): 459-460, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37502291

RESUMO

How to cite this article: Hegde A. Early Antibiotics in Septic Shock: A Desirable Goal but "Curb Your Enthusiasm". Indian J Crit Care Med 2023;27(7):459-460.

3.
Indian J Crit Care Med ; 27(12): 865-866, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38074955

RESUMO

How to cite this article: Hegde AV. Risk of Bleeding in Dengue: Making Predictions is Difficult Especially about the Future. Indian J Crit Care Med 2023;27(12):865-866.

4.
Indian J Crit Care Med ; 26(5): 543-544, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35719447

RESUMO

How to cite this article: Hegde A. Candida auris is Coming. Indian J Crit Care Med 2022;26(5):543-544.

5.
Indian J Crit Care Med ; 26(6): 663, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35836634

RESUMO

How to cite this article: Hegde A. Drug Levels in ICU - T or F. Indian J Crit Care Med 2022;26(6):663.

6.
Indian J Crit Care Med ; 26(1): 9-10, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-35110835

RESUMO

How to cite this article: Hegde A. Measurement of Interleukin-6 Levels in COVID: Illuminative or Illogical? Indian J Crit Care Med 2022;26(1):9-10.

7.
Indian J Crit Care Med ; 25(6): 608-609, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34316134

RESUMO

How to cite this article: Hegde A. Antibiotic Stewardship: Easy to Preach, Difficult to Practice. Indian J Crit Care Med 2021;25(6):608-609.

8.
Indian J Crit Care Med ; 25(Suppl 2): S127-S129, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-34345125

RESUMO

Most cases of severe malaria are caused by Plasmodium falciparum. Severe malaria is characterized by severe organ dysfunction. Both peripheral smear examination and rapid diagnostic test have a role in the diagnosis. Parenteral artesunate is clearly the drug of choice for the management of severe malaria. Parenteral artesunate should always be followed up with ACT. Most of the complications of severe malaria require supportive care only. The role of exchange transfusions in the management of severe malaria is questionable in the postartesunate era. Malaria in pregnancy can be quite severe and artesunate is now the drug of choice for all three trimesters. Vivax malaria is being increasingly recognized as a cause of severe malaria. The cause for this increased virulence is still not clear. Management of severe vivax malaria is similar to that of severe falciparum malaria. How to cite this article: Hegde A. Malaria in the Intensive Care Unit. Indian J Crit Care Med 2021;25(Suppl 2):S127-S129.

9.
Indian J Crit Care Med ; 24(Suppl 3): S98-S99, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32704212

RESUMO

How to cite this article: Hegde A. Diuretics in Acute Kidney Injury. Indian J Crit Care Med 2020;24(Suppl 3):S98-S99.

10.
Indian J Crit Care Med ; 24(Suppl 3): S83, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32704208

RESUMO

How to cite this article: Kulkarni AP, Hegde A, Ramakrishnan N. Acute Kidney Injury in the Critically Ill: Herein Lies the Problem! Indian J Crit Care Med 2020;24(Suppl 3):S83.

11.
Indian J Crit Care Med ; 24(1): 55-62, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32148350

RESUMO

AIM: The aim of this review article is not only to analyze the clinical burden of methicillin-resistant Staphylococcus aureus (MRSA) in intensive care unit (ICU) setting of India, along with the patterns of prevalence and its prevention measures, but also to focus on the new anti-MRSA research molecules which are in late stage of clinical development. BACKGROUND: Methicillin resistance is reported to be present in 13-47% of Staphylococcus aureus infections in India. Therapeutic options to combat MRSA are becoming less, because of emerging resistance to multiple classes of antibiotics. Intensive care units are the harbinger of multidrug-resistant organisms including MRSA and are responsible for its spread within the hospital. The emergence of MRSA in ICUs is associated with poor clinical outcomes, high morbidity, mortality, and escalating treatment costs. There is an urgency to bolster the antibiotic pipeline targeting MRSA. The research efforts for antibiotic development need to match with the pace of emergence of resistance, and new antibiotics are needed to control the impending threat of untreatable MRSA infections. REVIEW RESULTS: Fortunately, several potential antibiotic agents are in the pipeline and the future of MRSA management appears reassuring. CLINICAL SIGNIFICANCE: The authors believe that this knowledge may help form the basis for strategic allocation of current healthcare resources and the future needs. HOW TO CITE THIS ARTICLE: Mehta Y, Hegde A, Pande R, Zirpe KG, Gupta V, Ahdal J, et al. Methicillin-resistant Staphylococcus aureus in Intensive Care Unit Setting of India: A Review of Clinical Burden, Patterns of Prevalence, Preventive Measures, and Future Strategies. Indian J Crit Care Med 2020;24(1):55-62.

12.
Indian J Crit Care Med ; 23(Suppl 3): S178-S180, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31656373

RESUMO

How to cite this article: Hegde A. Approach to an Anemic Critically Ill Patient. Indian J Crit Care Med 2019;23(Suppl 3):S178-S180.

13.
Indian J Crit Care Med ; 23(6): 246, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31435140

RESUMO

How to cite this article: Hegde AV. Data is the New Gold! Indian J Crit Care Med 2019;23(6):246.

14.
Indian J Crit Care Med ; 23(Suppl 3): S171, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31656371

RESUMO

How to cite this article: Kulkarni AP, Samavedam S, Hegde A. Success is the Sum of Small Efforts! Indian J Crit Care Med 2019;23(Suppl 3):S171.

15.
Indian J Crit Care Med ; 23(Suppl 1): S64-S96, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31516212

RESUMO

How to cite this article: Kulkarni AP, Sengar M, Chinnaswamy G, Hegde A, Rodrigues C, Soman R, Khilnani GC, Ramasubban S, Desai M, Pandit R, Khasne R, Shetty A, Gilada T, Bhosale S, Kothekar A, Dixit S, Zirpe K, Mehta Y, Pulinilkunnathil JG, Bhagat V, Khan MS, Narkhede AM, Baliga N, Ammapalli S, Bamne S, Turkar S, Bhat KV, Choudhary J, Kumar R, Divatia JV. Indian Journal of Critical Care Medicine 2019;23(Suppl 1): S64-S96.

16.
J Assoc Physicians India ; 64(3): 78-79, 2016 03.
Artigo em Inglês | MEDLINE | ID: mdl-27731564

RESUMO

Pulmonary involvement is a fairly common complication of leptospirosis. A high dose of steroids is often used in the treatment of pulmonary leptospirosis. Here we report two cases who developed severe invasive fungal infections following the use of steroids for pulmonary leptospirosis. Routine use of steroids for pulmonary leptospirosis may do more harm than good as the evidence for this practice is sparse.


Assuntos
Leptospirose/diagnóstico , Pneumopatias/diagnóstico , Feminino , Humanos , Imunoglobulina M , Leptospira , Leptospirose/tratamento farmacológico , Leptospirose/mortalidade , Pneumopatias/tratamento farmacológico , Pneumopatias/mortalidade , Masculino , Pessoa de Meia-Idade , Esteroides/uso terapêutico , Resultado do Tratamento
17.
Indian J Crit Care Med ; 20(4): 216-25, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27186054

RESUMO

AIMS: To obtain information on organizational aspects, case mix and practices in Indian Intensive Care Units (ICUs). PATIENTS AND METHODS: An observational, 4-day point prevalence study was performed between 2010 and 2011 in 4209 patients from 124 ICUs. ICU and patient characteristics, and interventions were recorded for 24 h of the study day, and outcomes till 30 days after the study day. Data were analyzed for 4038 adult patients from 120 ICUs. RESULTS: On the study day, mean age, Acute Physiology and Chronic Health Evaluation (APACHE II) and sequential organ failure assessment (SOFA) scores were 54.1 ± 17.1 years, 17.4 ± 9.2 and 3.8 ± 3.6, respectively. About 46.4% patients had ≥1 organ failure. Nearly, 37% and 22.2% patients received mechanical ventilation (MV) and vasopressors or inotropes, respectively. Nearly, 12.2% patients developed an infection in the ICU. About 28.3% patients had severe sepsis or septic shock (SvSpSS) during their ICU stay. About 60.7% patients without infection received antibiotics. There were 546 deaths and 183 terminal discharges (TDs) from ICU (including left against medical advice or discharged on request), with ICU mortality 729/4038 (18.1%). In 1627 patients admitted within 24 h of the study day, the standardized mortality ratio was 0.67. The APACHE II and SOFA scores, public hospital ICUs, medical ICUs, inadequately equipped ICUs, medical admission, self-paying patient, presence of SvSpSS, acute respiratory failure or cancer, need for a fluid bolus, and MV were independent predictors of mortality. CONCLUSIONS: The high proportion of TDs and the association of public hospitals, self-paying patients, and inadequately equipped hospitals with mortality has important implications for critical care in India.

18.
Expert Rev Anti Infect Ther ; 22(6): 453-468, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38790080

RESUMO

INTRODUCTION: The rising challenge of carbapenem-resistant Enterobacterales (CRE) infections in Indian healthcare settings calls for clear clinical guidance on the management of these infections. The Indian consensus on the management of CRE infection in critically ill patients (ICONIC-II) is a follow-up of the ICONIC-I study, which was undertaken in 2019. AREAS COVERED: A modified Delphi method was used to build expert consensus on CRE management in India, involving online surveys, face-to - face expert meetings, and a literature review. A panel of 12 experts was formed to develop potential clinical consensus statements (CCSs), which were rated through two survey rounds. The CCSs were finalized in a final face-to - face discussion. The finalized CCSs were categorized as consensus, near consensus, and no consensus. EXPERT OPINION: The outcomes included 46 CCSs (consensus: 40; near consensus: 3; and no consensus: 3). The expert panel discussed and achieved consensus on various strategies for managing CRE infections, emphasizing the significance of existing and emerging resistance mechanisms, prompt and tailored empiric therapy, and use of combination therapies. The consensus statements based on the collective expertise of the panel can potentially assist clinicians in the management of CRE infections that lack high-level evidence.


Assuntos
Antibacterianos , Enterobacteriáceas Resistentes a Carbapenêmicos , Consenso , Estado Terminal , Técnica Delphi , Infecções por Enterobacteriaceae , Humanos , Infecções por Enterobacteriaceae/tratamento farmacológico , Infecções por Enterobacteriaceae/microbiologia , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Enterobacteriáceas Resistentes a Carbapenêmicos/efeitos dos fármacos , Enterobacteriáceas Resistentes a Carbapenêmicos/isolamento & purificação , Índia , Carbapenêmicos/farmacologia , Carbapenêmicos/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA